DrugPatentWatch Database Preview
Details for Patent: 8,232,264
Which drugs does patent 8,232,264 protect, and when does it expire?
Patent 8,232,264 protects VANOS and is included in one NDA.
This patent has eleven patent family members in nine countries.
This patent has eleven patent family members in nine countries.
Summary for Patent: 8,232,264
| Title: | Compositions and methods for enhancing corticosteroid delivery |
| Abstract: | The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70. |
| Inventor(s): | Gans; Eugene H. (Westport, CT), Wortzman; Mitchell S. (Scottsdale, AZ) |
| Assignee: | Medicis Pharmaceutical Corporation (Scottsdale, AZ) |
| Application Number: | 12/322,346 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,232,264
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicis | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,232,264
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,220,424 | Compositions and methods for enhancing corticosteroid delivery | ➤ Try a Free Trial |
| 7,771,733 | Compositions and methods for enhancing corticosteroid delivery | ➤ Try a Free Trial |
| 6,765,001 | Compositions and methods for enhancing corticosteroid delivery | ➤ Try a Free Trial |
| 7,794,738 | Compositions and methods for enhancing corticosteroid delivery | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 8,232,264
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2002360589 | ➤ Try a Free Trial | |||
| Brazil | 0215254 | ➤ Try a Free Trial | |||
| Canada | 2471041 | ➤ Try a Free Trial | |||
| China | 1617730 | ➤ Try a Free Trial | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
